Sildenafil vs Tadalafil for Erectile Dysfunction
Comparative Efficacy
- The American Urological Association suggests that both sildenafil and tadalafil are equally effective first-line treatments for erectile dysfunction, with the primary difference being tadalafil's longer duration of action (up to 36 hours vs 4-5 hours) 1, 2
- Success rates for sexual intercourse: Sildenafil achieves 69% success (range 52-85%) versus placebo 35.5%, while tadalafil achieves 69% success (range 50-85%) versus placebo 33% 2
- Erection improvement: Both agents improve erections in 73-88% of patients compared to 26-32% with placebo, according to the Annals of Internal Medicine 2
Key Pharmacological Differences
- The maximum frequency of sildenafil is once daily 1
- The nitrate washout period for sildenafil is at least 24 hours, and for tadalafil, it is at least 24-48 hours due to its longer half-life 3, 4
Dose-Response Relationships
- Sildenafil shows dose-related improvement seen from 25 mg to 50 mg, but less additional benefit from 50 mg to 100 mg, as reported by the Annals of Internal Medicine 2
- Tadalafil has no significant dose-response difference between 5 mg, 10 mg, and 20 mg for on-demand dosing, according to the Annals of Internal Medicine 2
Adverse Effect Profiles
- Common side effects of both agents include headache, flushing, dyspepsia, nasal congestion, myalgia, visual disturbances, and dizziness, with a low rate of serious adverse events (<2%) 1, 3, 5
Special Populations
- Both agents are effective in patients with diabetes, though response is less robust than in the general population, with the American Urological Association recommending their use 1
- Both agents are effective but response is diminished compared to general ED population in post-prostatectomy patients, according to the Journal of Urology 1
Critical Safety Considerations
- Absolute contraindication: Never use with nitrates due to severe hypotension risk, as stated by Praxis Medical Insights 4
- Cardiovascular assessment: ED diagnosis provides opportunity to evaluate cardiovascular risk factors, according to the Journal of Urology 1